PET/CT Imaging Companion Study To ACTG A5314

CompletedOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

December 8, 2016

Study Completion Date

December 8, 2016

Conditions
HIVInflammationAtherosclerosis
Interventions
DRUG

Folic Acid

1 mg folic acid once daily

DRUG

Placebo

placebo once weekly

DRUG

Low Dose Methotrexate

An anti-inflammatory drug

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Brigham and Women's Hospital

OTHER

collaborator

Harvard School of Public Health (HSPH)

OTHER

collaborator

University of California, San Francisco

OTHER

lead

Massachusetts General Hospital

OTHER

NCT02312219 - PET/CT Imaging Companion Study To ACTG A5314 | Biotech Hunter | Biotech Hunter